Sigma Planning Corp Raises Stock Holdings in Tempus AI, Inc. (NASDAQ:TEM)

Sigma Planning Corp lifted its holdings in Tempus AI, Inc. (NASDAQ:TEM) by 43.9% in the fourth quarter, HoldingsChannel reports. The firm owned 33,638 shares of the company’s stock after purchasing an additional 10,269 shares during the quarter. Sigma Planning Corp’s holdings in Tempus AI were worth $1,136,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of TEM. First Horizon Advisors Inc. bought a new stake in Tempus AI during the third quarter worth approximately $30,000. FNY Investment Advisers LLC purchased a new position in shares of Tempus AI in the 4th quarter worth approximately $67,000. Vestor Capital LLC bought a new position in shares of Tempus AI during the 3rd quarter valued at approximately $153,000. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Tempus AI during the 4th quarter valued at approximately $178,000. Finally, Stifel Financial Corp purchased a new stake in Tempus AI during the 3rd quarter valued at $218,000. Institutional investors own 24.22% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on TEM shares. Loop Capital cut their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research report on Tuesday, January 14th. Bank of America lifted their price target on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Wolfe Research started coverage on shares of Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price objective on the stock. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and boosted their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Finally, TD Cowen reiterated a “buy” rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $58.55.

Insiders Place Their Bets

In other Tempus AI news, major shareholder Bradley A. Keywell sold 265,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was sold at an average price of $35.10, for a total transaction of $9,301,500.00. Following the completion of the sale, the insider now owns 15,218,365 shares in the company, valued at $534,164,611.50. This represents a 1.71 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David R. Epstein sold 620 shares of Tempus AI stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $41.81, for a total value of $25,922.20. Following the completion of the transaction, the director now owns 27,894 shares in the company, valued at $1,166,248.14. This represents a 2.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,583,467 shares of company stock worth $130,542,311 in the last three months.

Tempus AI Trading Up 2.2 %

Shares of NASDAQ:TEM opened at $69.57 on Tuesday. The business’s 50 day moving average is $50.88 and its 200 day moving average is $52.03. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Monday, February 24th. The company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.18). Sell-side analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.